Clinical TrialsSearch results
Number of results: 2972
Other
- Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)
- Steroid-sensitive nephrotic syndrome
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01
No Longer Recruiting
- ONO-4059-10:Phase 3 study in patients with steroid-resistant pemphigus
- steroid-resistant pemphigus
- Osawa Masahiro
- 2022-04-27
Other
- A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone for steroid-resistant nephrotic syndrome in children: A randomized controlled study
- Steroid-resistant nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2005-08-01
Other
- Treatment for steroid-resistant nephrotic syndrome in children: a combination of cyclosporine and prednisolone in minimal change and a combination of methylprednisolone, cyclosporine and prednisolone in FSGS
- Steroid-resistant nephrotic syndrome in children
- Japanese Study Group of Renal Disease in Children
- 2005-08-01
Completed
- Dose proportional study after single doses intranasal administration of NRL-1 in healthy Japanese subjects
- status epilepticus or seizures that may progress to status epilepticus
- Takazawa Kenji
- 2022-08-15
Not yet recruiting
- DRAGON II
- Stargardt Disease
- Mata Nathan
- 2024-07-07
Other
- A Phase I/II study of JR-031 for the patients of standard primary treatment-refractory acute graft-versus-host disease (acute GVHD) after hematopoietic stem cell transplantation
- Standard primary treatment-refractory acute GVHD
- JCR pharmaceuticals Co.,Ltd
- 2009-02-19
Other
- A Phase II Study of Nivolumab and Ipilimumab in Combination with Chemotherapy after Lung SBRT in Stage IV NSCLC.
- Stage IV non-small cell lung cancer
- Hosomi Yukio
- 2022-03-22
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01
Other
- Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
- Stage IIIB/IV non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-01